2-(5-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

4-Phenyl-3H-1,2,4-triazole-3,5(4H)-dione, 95.0%, 250mg

N'-(4-Bromo-benzyl)-N,N-dimethyl-ethane-1,2-diamine, 95.0%, 1g

3-tert-Butyl-1H-pyrazol-5-amine, 98.0%, 1g

4-Acetylamino-1-Boc-piperidine, 97.0%, 1g

Impact magnifier. Magnification: 10x doublet. With Aplanatic lens Ø 20 mm. Field of view 20 mm

2-(3-AZABICYCLO[3.2.1]OCTAN-8-YL)ETHAN-1-OL HCL, 95.0%, 100mg

6-BROMO-1-NAPHTHONITRILE, 95.0%, 250mg

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,3]dioxolo[4,5-b]pyridine, 95.0%, 100mg

(1S,2S)-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol, 95.0%, 500g

1,3,7-triazaspiro[4.4]nonane-2,4-dione hydrochloride, 95%, 1g

Diethyl 2-phenylmalonate, 95.0%, 100g

2-Amino-6-chloro-4-nitrophenol>98.0%(T)5g